Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis

Daniel Barkan; Zhen Liu; James C. Sacchettini; Michael S. Glickman

doi:10.1016/j.chembiol.2009.04.001

Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis

Daniel Barkan, Zhen Liu, James C. Sacchettini, Michael S. Glickman^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

101 Scopus citations

Abstract

Mycobacterium tuberculosis infection remains a major global health problem complicated by escalating rates of antibiotic resistance. Despite the established role of mycolic acid cyclopropane modification in pathogenesis, the feasibility of targeting this enzyme family for antibiotic development is unknown. We show through genetics and chemical biology that mycolic acid methyltransferases are essential for M. tuberculosis viability, cell wall structure, and intrinsic resistance to antibiotics. The tool compound dioctylamine, which we show acts as a substrate mimic, directly inhibits the function of multiple mycolic acid methyltransferases, resulting in loss of cyclopropanation, cell death, loss of acid fastness, and synergistic killing with isoniazid and ciprofloxacin. These results demonstrate that mycolic acid methyltransferases are a promising antibiotic target and that a family of virulence factors can be chemically inhibited with effects not anticipated from studies of each individual enzyme.

Original language	English
Pages (from-to)	499-509
Number of pages	11
Journal	Chemistry and Biology
Volume	16
Issue number	5
DOIs	https://doi.org/10.1016/j.chembiol.2009.04.001
State	Published - 29 May 2009
Externally published	Yes

Bibliographical note

Funding Information:
The authors would like to thank Marcel Behr for kindly providing BCG Russia, Sabine Ehrt and Dirk Schnappinger for providing the tet-controlled expression system, and Susan Massarella for technical assistance. D.B. is supported in part by funds granted by the Michael and Ethel L. Cohen Foundation and by National Institutes of Health (NIH) award T32 AI055409. This work is supported by NIH award AI53417 to M.S.G. and by NIH PO1AIO68135 and the Robert A. Welch Foundation to J.C.S.

Keywords

CHEMBIO
MICROBIO

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.chembiol.2009.04.001

Cite this

@article{412e86d2d4c74aeeb46d2bb40cc0aeb8,

title = "Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis",

abstract = "Mycobacterium tuberculosis infection remains a major global health problem complicated by escalating rates of antibiotic resistance. Despite the established role of mycolic acid cyclopropane modification in pathogenesis, the feasibility of targeting this enzyme family for antibiotic development is unknown. We show through genetics and chemical biology that mycolic acid methyltransferases are essential for M. tuberculosis viability, cell wall structure, and intrinsic resistance to antibiotics. The tool compound dioctylamine, which we show acts as a substrate mimic, directly inhibits the function of multiple mycolic acid methyltransferases, resulting in loss of cyclopropanation, cell death, loss of acid fastness, and synergistic killing with isoniazid and ciprofloxacin. These results demonstrate that mycolic acid methyltransferases are a promising antibiotic target and that a family of virulence factors can be chemically inhibited with effects not anticipated from studies of each individual enzyme.",

keywords = "CHEMBIO, MICROBIO",

author = "Daniel Barkan and Zhen Liu and Sacchettini, {James C.} and Glickman, {Michael S.}",

note = "Funding Information: The authors would like to thank Marcel Behr for kindly providing BCG Russia, Sabine Ehrt and Dirk Schnappinger for providing the tet-controlled expression system, and Susan Massarella for technical assistance. D.B. is supported in part by funds granted by the Michael and Ethel L. Cohen Foundation and by National Institutes of Health (NIH) award T32 AI055409. This work is supported by NIH award AI53417 to M.S.G. and by NIH PO1AIO68135 and the Robert A. Welch Foundation to J.C.S. ",

year = "2009",

month = may,

day = "29",

doi = "10.1016/j.chembiol.2009.04.001",

language = "אנגלית",

volume = "16",

pages = "499--509",

journal = "Chemistry and Biology",

issn = "1074-5521",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis

AU - Barkan, Daniel

AU - Liu, Zhen

AU - Sacchettini, James C.

AU - Glickman, Michael S.

N1 - Funding Information: The authors would like to thank Marcel Behr for kindly providing BCG Russia, Sabine Ehrt and Dirk Schnappinger for providing the tet-controlled expression system, and Susan Massarella for technical assistance. D.B. is supported in part by funds granted by the Michael and Ethel L. Cohen Foundation and by National Institutes of Health (NIH) award T32 AI055409. This work is supported by NIH award AI53417 to M.S.G. and by NIH PO1AIO68135 and the Robert A. Welch Foundation to J.C.S.

PY - 2009/5/29

Y1 - 2009/5/29

N2 - Mycobacterium tuberculosis infection remains a major global health problem complicated by escalating rates of antibiotic resistance. Despite the established role of mycolic acid cyclopropane modification in pathogenesis, the feasibility of targeting this enzyme family for antibiotic development is unknown. We show through genetics and chemical biology that mycolic acid methyltransferases are essential for M. tuberculosis viability, cell wall structure, and intrinsic resistance to antibiotics. The tool compound dioctylamine, which we show acts as a substrate mimic, directly inhibits the function of multiple mycolic acid methyltransferases, resulting in loss of cyclopropanation, cell death, loss of acid fastness, and synergistic killing with isoniazid and ciprofloxacin. These results demonstrate that mycolic acid methyltransferases are a promising antibiotic target and that a family of virulence factors can be chemically inhibited with effects not anticipated from studies of each individual enzyme.

AB - Mycobacterium tuberculosis infection remains a major global health problem complicated by escalating rates of antibiotic resistance. Despite the established role of mycolic acid cyclopropane modification in pathogenesis, the feasibility of targeting this enzyme family for antibiotic development is unknown. We show through genetics and chemical biology that mycolic acid methyltransferases are essential for M. tuberculosis viability, cell wall structure, and intrinsic resistance to antibiotics. The tool compound dioctylamine, which we show acts as a substrate mimic, directly inhibits the function of multiple mycolic acid methyltransferases, resulting in loss of cyclopropanation, cell death, loss of acid fastness, and synergistic killing with isoniazid and ciprofloxacin. These results demonstrate that mycolic acid methyltransferases are a promising antibiotic target and that a family of virulence factors can be chemically inhibited with effects not anticipated from studies of each individual enzyme.

KW - CHEMBIO

KW - MICROBIO

UR - http://www.scopus.com/inward/record.url?scp=65749086909&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2009.04.001

DO - 10.1016/j.chembiol.2009.04.001

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 19477414

AN - SCOPUS:65749086909

SN - 1074-5521

VL - 16

SP - 499

EP - 509

JO - Chemistry and Biology

JF - Chemistry and Biology

IS - 5

ER -

Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this